Nov 2, 2018
CV outcomes in patients with type 2 diabetes, canagliflozin,
cardiorespiratory fitness, the value of randomized trials, and the
most important paper of 2018 are reviewed in this week’s
Recent Facebook Posts
This podcast delivers Dr. John Mandrola’s summary and perspective on top news of the week that cardiologists can’t miss. This podcast is intended for US health professionals only.
Having trouble logging in?